HomeHealth articleswilson's diseaseWhat Are the Benefits of Trientine in Wilson’s Disease Management?

Trientine: Uses, Dosage, Safety, and More.

Verified dataVerified data
0

13 min read

Share

Trientine is a chelating drug used to treat Wilson's disease, a rare illness that causes copper buildup in organs.

Medically reviewed by

Dr. Rajesh Gulati

Published At November 28, 2023
Reviewed AtNovember 28, 2023

Overview

Trientine is a medicine used to treat Wilson's illness, a rare genetic ailment that affects the body’s mechanism to metabolize copper effectively. This causes excessive copper accumulation in numerous organs, including the liver, brain, and cornea, which can lead to major health concerns.

Trientine is a chelating agent that binds to copper in the body and aids in its elimination via urine. It prevents the detrimental consequences of copper buildup in organs and tissues by lowering copper levels. Trientine is generally administered when alternative therapies, such as Penicillamine, are ineffective or poorly tolerated. Trientine was approved by the FDA (Food and Drug Administration) on 28 April 2022 for treating Wilson’s disease in adult patients.

Trientine protects the body by binding to copper and aiding in its removal. Dosing is determined by the severity of the disease and is administered orally via capsules or tablets. Regular monitoring is critical, especially when penicillamine intolerance or ineffectiveness is present. The safety of Trientine is well established. However, neurological side effects, allergies, and renal problems must be considered. Pregnant and breastfeeding women, as well as certain communities, require tailored methods. This abstract briefly explains Trientine's role, application, and significant concerns.

Indications

Trientine is used to treat Wilson's disease in people who are intolerant to Penicillamine or when Penicillamine treatment is ineffective. Wilson's illness is a rare hereditary disorder defined by an inability of the body to effectively metabolize copper, resulting in its accumulation in multiple organs, mainly the liver and brain. This copper buildup can lead to major health problems. Indications are listed below:

Wilson’s Disease:

Trientine is used to treat Wilson's disease, a disorder in which the body cannot efficiently excrete excess copper. Trientine works as a chelating agent, removing excess copper from the body and avoiding its detrimental accumulation in organs and tissues. This can help manage Wilson's disease symptoms and prevent problems caused by copper poisoning.

Penicillamine Intolerance or Ineffectiveness:

In some circumstances, the usual treatment for Wilson's illness, which involves Penicillamine, may not be well accepted by patients due to side effects or allergies. In some circumstances, Penicillamine may not be successful in controlling copper levels. Trientine can be considered as an alternative therapy option in such cases.

Therapeutic Usage

Trientine's medicinal use primarily focuses on its role in treating Wilson's disease, a rare hereditary illness characterized by aberrant copper accumulation in numerous body organs. Trientine is a chelating drug that lowers and regulates copper levels in people with Wilson's disease. Trientine is used therapeutically in the following ways:

Wilson's Disease Treatment:

Trientine is used to treat Wilson's illness, characterized by a genetic abnormality that inhibits the body's capacity to metabolize and eliminate copper effectively. This causes copper accumulation in many organs, mainly the liver and brain, which can cause serious health problems. Trientine aids in the removal of copper ions from the bloodstream by producing stable complexes that are eliminated in the urine. This lowers the overall copper burden in the body and aids in the prevention of the adverse effects of copper accumulation.

Alternative to Penicillamine: Trientine is frequently investigated as a therapy option for people who cannot take Penicillamine or when penicillamine is ineffective at reducing copper levels. Trientine can reduce copper and treat the symptoms of Wilson's disease in people with adverse reactions or allergies to Penicillamine.

Maintenance Therapy:

Trientine can be used for long-term maintenance therapy after copper levels have been successfully decreased to safe levels after initial treatment. During this time, monitoring copper levels and overall health regularly is critical to ensure that copper accumulation does not return.

Individualized Treatment:

A healthcare provider determines the dosing and duration of Trientine therapy based on the severity of the condition, the patient's reaction to treatment, and their individual medical circumstances. Regular medical check-ups and copper level monitoring are essential for ensuring treatment effectiveness and adjusting therapy as needed.

Dosage and Forms

Trientine comes in a variety of dose forms and strengths. Specific formulations and dosages may differ depending on the manufacturer and region, so following healthcare provider's and medicine box directions is critical. Trientine is available in the following dosage forms and strengths:

Capsules -Trientine is frequently available in pill form. Capsules are easy to swallow and often come in various strengths, allowing for dosing flexibility. Capsule strengths that are commonly used include:

  • 250 milligram (mg) capsules.

  • 300 milligram capsules.

Tablets:

Trientine may be available as a tablet. Tablets are another simple method of taking the drug orally. Tablet strengths can range from:

  • Tablets of 250 mg and 300 mg.

Dosage and Administration

Trientine dosage is determined by the severity of Wilson's disease and the body's response to the medicine. Typically, the initial dosage is greater and is subsequently reduced as copper levels increase. The daily dose is frequently divided into two to four smaller doses to maintain regular blood levels of the medicine.

Trientine dosages range from 750 mg to 2,250 mg per day, which can be divided into multiple doses. However, the healthcare provider will establish the appropriate dosage for everyone.

Administration

Trientine is usually available in capsule or tablet form and is administered orally. Here are some general administration guidelines:

Follow The Doctor's Prescription: Always take Trientine precisely as the physician directs. Only change or stop using the prescribed dosage after consulting the physician's doctor.

Timing: Trientine is often taken on an empty stomach, at least one hour before or two hours after meals. This improves its absorption. However, depending on particular requirements, the recommendation from the doctor may differ.

Dosage Division: If the recommended dosage is divided into many doses throughout the day, follow the doctor's instructions on the timing of each dose. This helps to keep drug levels stable in the bloodstream.

Swallow Whole: With a glass of water, swallow the Trientine capsules or tablets whole. Unless otherwise directed by the doctor, do not crush, break, or chew the capsules or tablets.

Consistency: To maintain a consistent pattern, take Trientine at the same times each day.

Regular Monitoring: During Trientine treatment, the physician will most likely frequently test the copper levels and overall health. This helps to ensure the medication's effectiveness and enables any necessary dosage modifications.

Duration: Trientine treatment is often long-term and often lifetime. Even if the symptoms improve, the person must continue to take the medication as prescribed by the doctor to prevent copper accumulation from returning.

Contraindications:

Contraindications are conditions, situations, or variables that render using a specific prescription, such as Trientine, potentially dangerous or improper. While Trientine is generally well accepted, there are a few contraindications and precautions to be aware of before using it. Review medical history with a healthcare professional to confirm that Trientine is safe for the individual. Here are some Trientine contraindications and precautions:

Hypersensitivity to Trientine: Individuals with known hypersensitivity (allergic response) to Trientine or its components should not take this drug.

Severe Renal Impairment: Trientine is mainly eliminated through the kidneys. Individuals with significant renal impairment (low kidney function) may be at risk of further kidney injury or drug buildup.

Precautions:

  • Mild to Moderate Renal Impairment: Individuals with mild-to-moderate renal impairment should use Trientine cautiously. Dosing changes may be required depending on renal function.

  • Neurological Disorders: Trientine has been connected with neurological adverse effects such as tremors, dystonia, and other movement abnormalities. Individuals with pre-existing neurological diseases or a history of neurological illnesses should use Trientine cautiously.

  • Pregnancy and Breastfeeding: Trientine's safety during pregnancy and breastfeeding is unknown. Pregnant or breastfeeding individuals should consult their healthcare provider before using Trientine to consider the risks and benefits.

  • Drug Interactions: Trientine may have drug interactions with other drugs. To avoid potential interactions, inform the medical practitioner about all drugs, supplements, and herbal products the patient is using.

  • Monitoring: During Trientine treatment, copper levels, renal function, and overall health must be monitored on a regular basis.

  • Allergic Responses: While uncommon, allergic responses to medications can occur. Seek medical care immediately if there are symptoms of an allergic reaction, such as a rash, itching, swelling, severe dizziness, or difficulty breathing.

  • Pediatric and Geriatric Use: The safety and effectiveness of Trientine in children and the elderly may differ. In these age ranges, special considerations may apply.

Drug Interactions

Trientine, like numerous other medications, might interact with others, potentially reducing their efficacy or increasing the risk of unwanted effects. Before beginning Trientine, ensure the healthcare professional is aware of all drugs, vitamins, and herbal items a person uses. The following are some examples of Trientine medication interactions:

  • Zinc Supplements: Taking zinc supplements at the same time as Trientine may limit Trientine absorption. It is generally suggested that Trientine and zinc supplements be taken at least a few hours apart.

  • Iron Supplements: Iron supplements can also interfere with Trientine absorption. Iron supplements and Trientine should be taken at different times, like zinc.

  • Antacids and Calcium Supplements: Antacids and calcium supplements containing aluminum, magnesium, or calcium can inhibit Trientine absorption. Trientine should be taken a few hours before or after these products.

  • Foods and Dairy Products: Certain foods, particularly those heavy in calcium or minerals, can limit Trientine absorption. Taking Trientine on an empty stomach or avoiding calcium-rich foods near the time of administration may assist in reducing this interaction.

  • Penicillamine and Other Chelating Agents: Trientine and Penicillamine treat Wilson's disease. Combining these drugs raises the possibility of copper deficiency. If the patient needs to go from Penicillamine to Trientine, the doctor will walk the patient through the process.

  • NSAIDs (Nonsteroidal Anti-inflammatory Drugs): NSAIDs such as Ibuprofen and Naproxen can interact with Trientine and increase the risk of gastrointestinal bleeding. While taking Trientine, using NSAIDs cautiously and under medical supervision is best.

  • Other Drugs: Trientine may interact with other drugs that influence stomach acidity or nutrition absorption. Always provide the healthcare provider with a complete list of medications the patient takes so that potential interactions can be thoroughly assessed.

For Patients

Why Is Trientine Prescribed?

  • Trientine has been authorized to treat adult patients with stable Wilson's disease who are de-copped and Penicillamine tolerant.

What Are the Administration Instructions to Be Followed?

  • Stop taking Penicillamine before beginning Trientine.

  • Take Trientine on an empty stomach, at least one hour before or after meals, and at least one hour apart from any other food or milk.

  • Avoid taking mineral supplements simultaneously (e.g., iron, zinc, calcium, magnesium). If the usage of mineral supplements is unavoidable,

  • Iron supplements: Take Trientine at least two hours before or two hours after taking an iron supplement.

  • Other mineral supplements: Take Trientine at least one hour before or two hours after taking other mineral supplements.

  • Give Trientine at least one hour apart from any other oral medication.

  • Keep the tablets in the blister pack until just before dosage.

  • Swallow Trientine tablets whole without crushing, chewing, or dissolving them. The scored tablet can be cut into two halves for patients who have trouble swallowing the tablet whole. After the blister has been opened, do not save the tablet for later use.

  • Trientine should not be used in people who cannot swallow tablets.

What Are the Diet Restrictions to Be Followed?

While Trientine does not have any stringent dietary limitations, several dietary recommendations can help enhance its effectiveness and avoid potential complications. Here are some dietary tips to follow when using Trientine:

Avoid Consuming Copper-Rich Foods: Because Trientine regulates copper accumulation in Wilson's disease, it's best to avoid eating foods naturally high in copper. These are some examples:

  • Organ meats (liver, kidney, and so on).

  • Crab, lobster, and oysters are examples of shellfish.

  • Nuts and seeds, particularly cashews, almonds, and sunflower seeds.

  • Cocoa and chocolate.

  • Mushrooms.

Reduced consumption of these high-copper meals can aid the medication's action in reducing copper levels.

Medication and Meal Timing: Trientine is frequently taken on an empty stomach to maximize absorption. It may be recommended that the person take it at least one hour before or two hours after meals. Following this schedule can assist in ensuring that the drug is effectively absorbed.

Supplements and Antacids: Certain supplements and antacids can interfere with Trientine absorption like zinc supplements, iron supplements, calcium supplements, and antacids containing aluminum, magnesium, or calcium. To minimize potential problems, take these vitamins and antacids at least a few hours before the Trientine dose.

Discuss Dietary Changes: If the person is thinking about making large changes to the diet or adding new supplements, talk to healthcare professionals first. They can advise on how these changes may affect the Trientine treatment.

Hydration: It is critical to stay hydrated while taking any medication. Drinking adequate water can help support overall health and good body function.

Work with the Healthcare Provider: The healthcare professional will be the most knowledgeable about specific medical conditions and needs.

What are the Side Effects of Trientine Usage?

Trientine, like any medicine, has the potential to cause negative effects. These adverse effects will not affect everyone, and their severity will vary from person to person. Here are some of the possible adverse effects of Trientine:

Skin Reactions:

  • Rash.

  • Itching or hives.

  • Skin redness.

Disturbances in the Gastrointestinal System:

  • Nausea.

  • Vomiting.

  • Discomfort or pain in the abdomen.

  • Diarrhea.

  • Appetite loss.

Symptoms of a Neurological Disorder:

  • Tremors.

  • Dystonia (uncontrollable muscular contractions.)

  • Disorders of movement.

  • Nerve injury (peripheral neuropathy).

Abnormalities in Liver Function:

  • Increased liver enzymes.

  • Abnormal values in liver function tests.

Impairment of Kidney Function:

  • Changes in kidney function, particularly in people who already have kidney problems.

Abnormalities in the Blood:

  • Blood cell count changes (rare).

Reactions to Allergens:

  • Anaphylactic responses (very rare but potentially fatal).

For Doctors

What Are the Indications of Trientine Tetrahydrochloride?

  • Common Variable Immunodeficiency (CVID): One of the most frequent primary immunodeficient conditions is common variable immunodeficiency (CVID). It is distinguished by low levels of immunoglobulins, particularly IgG, which increases the risk of infection.

  • X-Linked Agammaglobulinemia (XLA) and Autosomal Recessive Agammaglobulinemia (ARA): These are rare hereditary illnesses in which the body is unable to form mature B cells and immunoglobulins, resulting in severe immunological deficits.

  • Hyper IgM Syndrome: It is an uncommon illness characterized by high amounts of IgM antibodies but low levels of other immunoglobulins, making the patient susceptible to infections.

  • Selective IgA Deficiency: Individuals with Selective IgA Deficiency have very low or nonexistent levels of IgA antibodies, which can lead to recurring infections, particularly in the respiratory and gastrointestinal tracts.

  • Other Rare Primary Immunodeficiencies: Other rare primary immunodeficiency illnesses may necessitate immunoglobulin replacement therapy.

Considerations for Dosage Alterations of Trientine Tetrahydrochloride

  • Initial Dosing: The initial dose of Trientine is frequently greater and is subsequently reduced when copper levels improve. When establishing the starting dosage, physicians examine the patient's copper levels, overall health, and any pre-existing medical issues.

  • Copper Level Monitoring: Copper levels in the blood are constantly monitored by doctors. If copper levels remain high or fall too quickly, the dosage may need to be modified to obtain the best balance.

  • Response to Treatment: If a patient's copper levels do not respond effectively to the present dosage, the doctor may consider raising the dosage to obtain the desired therapeutic effect.

  • Side Effects: If a patient has substantial side effects or adverse reactions to Trientine, the doctor may alter the dosage or temporarily withdraw the medicine to address these unwanted effects.

  • Renal Function: Because Trientine is mostly eliminated through the kidneys, patients with renal impairment may require dose changes. Lower doses may be required to avoid further renal injury.

  • Pediatric Patients: Children's dosing is usually changed according to their age, weight, and growth. Pediatric patients must be closely monitored to ensure proper dose and response.

  • Elderly Patients: Patients above the age of 65 may require dose adjustments due to changes in kidney function and overall health.

  • Pregnancy and Breastfeeding: Doctors may change the dosage in pregnant or breastfeeding women to balance the benefits of controlling copper levels with potential dangers to the mother, fetus, or newborn.

  • Long-Term Maintenance: Doctors may adjust the dosage for long-term maintenance once copper levels are steady and adequate.

Use in Specific Populations:

  • Adults: Trientine is often used to treat Wilson's disease in adults. Adult dose and administration instructions are largely comparable to those stated previously. During treatment, copper levels, renal function, and overall health must be monitored on a regular basis.

  • Children and Adolescents: Trientine can also treat Wilson's disease in children and adolescents. However, depending on the child's age, weight, and reaction to treatment, dosing may need to be changed. Pediatric patients should have their growth, development, and potential adverse effects adequately monitored.

  • Elderly: Trientine can be utilized in older people with Wilson's disease. However, vigilance is suggested due to the possibility of age-related changes in renal function. Dosing changes may be required in this age group to ensure the medication's safety and effectiveness.

  • Pregnancy: Trientine's safety during pregnancy has not been thoroughly demonstrated. It should be used during pregnancy only if the possible advantages outweigh the hazards. Pregnant women with Wilson's disease should consult their healthcare professional to establish the best method to manage their condition while keeping the mother and the developing fetus in mind.

  • Breastfeeding: Trientine is secreted in breast milk, and its nursing safety has not been thoroughly researched. Individuals with Wilson's disease should see their healthcare professional to weigh the risks and advantages of using Trientine while breastfeeding. Alternatives may be considered if necessary.

  • Renal Impairment: Trientine is mostly eliminated by the kidneys. Individuals with mild to moderate renal impairment should use Trientine with caution. Dosing modifications may be required to avoid future renal injury or medication accumulation.

  • Neurological Disorders: Individuals with pre-existing neurological diseases or a history of neurological symptoms should be thoroughly monitored while taking Trientine. Tremors and movement problems have been linked to the medication's neurological adverse effects.

What Is the Clinical Pharmacology of Trientine?

Mechanism of Action:

Trientine is a chelating agent, forming stable compounds with copper ions in the circulation. The kidneys then eliminate these complexes through urine, lowering the body's overall copper burden. Trientine helps avoid the harmful effects of copper accumulation in organs such as the liver and brain by reducing copper levels.

Pharmacokinetics:

  • Trientine pharmacokinetics can differ amongst individuals due to age, kidney function, and illness severity.

  • Trientine's half-life (the amount of time it takes for half of the drug to be removed from the body) can range from several hours to roughly 12 hours, depending on the individual.

  • Because trientine is primarily removed through the kidneys, people with impaired kidney function may need to reduce their dosage to avoid further kidney damage.

Absorption:

Trientine is taken orally, and its absorption from the gastrointestinal tract varies. Food consumption and the presence of other chemicals can all impact its absorption. Taking Trientine on an empty stomach, usually one hour before or two hours after meals aids absorption.

Distribution:

Trientine's principal target in the bloodstream is copper ions. It produces complexes with copper that are less likely to be absorbed or disseminated to tissues after it binds to it. The complexes are then excreted in the urine.

Metabolism and Elimination:

Trientine is processed and eliminated in the body in a limited amount. The majority of the medication is eliminated in urine unaltered. This renal excretion is the major method of removing excess copper from the body.

Drug Interactions:

Trientine can interact with a number of drugs and substances. Concurrent usage of zinc or iron supplements and some antacids, for example, can limit Trientine absorption. Other medications that may be used near Trientine dosages should also be investigated for potential interactions.

Clinical Use:

Trientine is usually started at a greater dose and then gradually reduced depending on the patient's response and copper levels. During treatment, it is critical to assess copper levels, renal function, and overall health on a regular basis.

Special Populations:

Dosing changes may be required in pediatric, geriatric, pregnant, and breastfeeding populations, as well as in people with renal impairment or neurological diseases.

Drug Toxicity

Trientine tetrahydrochloride (Trientine HCl) is generally well tolerated when administered as directed by a healthcare practitioner. However, like with any prescription, there is a risk of drug toxicity if the authorized dosage is exceeded or if a person is exceptionally sensitive to the treatment. Here are some crucial facts to remember about Trientine medication toxicity:

  • Copper Depletion: Trientine's principal action method is to bind to excess copper and aid in its elimination from the body. While this is good for people with Wilson's disease who have high copper levels, excessive usage of Trientine may lead to copper depletion in the body, which is required for many enzymatic functions. This is why it is critical to check copper levels during treatment carefully.

  • Kidney Function: Trientine is mostly excreted by the kidneys. Individuals with reduced renal function may be more prone to medication buildup, which could lead to toxicity. Dosing modifications are frequently required in kidney-impaired patients to prevent further harm.

  • Neurological Effects: Trientine can have adverse neurological effects, particularly at higher doses or in very sensitive persons. Tremors, movement abnormalities, and peripheral neuropathy are possible side effects. It is critical to monitor for such effects regularly, and any concerned neurological symptoms should be reported to a healthcare specialist.

  • Gastrointestinal Disturbances: Trientine use may result in gastrointestinal adverse effects such as nausea, vomiting, and diarrhea. While these symptoms are often tolerable, untreated severe or chronic gastrointestinal problems may contribute to dehydration or other consequences.

  • Allergic Reactions: Although uncommon, allergic reactions to drugs are possible. Individuals should be on the lookout for symptoms of allergic reactions, such as skin rashes, itching, swelling, or difficulty breathing. Severe allergic reactions, such as anaphylaxis, can be fatal and necessitate emergency medical intervention.

  • Drug Interactions: Drug interactions with other medications or supplements may raise the risk of drug toxicity. Concurrent use of certain antacids, zinc supplements, or iron supplements, for example, may impair Trientine absorption and efficacy.

  • Individual Variability: Each person's reaction to medication is distinct because of factors like heredity, overall health, and sensitivity. Some people may be more susceptible to adverse effects or toxicity at lower doses.

  • Regular Monitoring: Regular medical check-ups, blood tests, and copper level monitoring are required throughout Trientine treatment. This ensures that the medication is acting properly and that any potential indicators of toxicity are noticed as soon as possible.

Source Article IclonSourcesSource Article Arrow
Dr. Rajesh Gulati
Dr. Rajesh Gulati

Family Physician

Tags:

wilson's diseasetrientine
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

wilson's disease

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy